Viewing Study NCT02392793


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-02-19 @ 5:33 PM
Study NCT ID: NCT02392793
Status: COMPLETED
Last Update Posted: 2021-02-09
First Post: 2015-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
Sponsor: St. Jude Children's Research Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Childhood Solid Tumors View
Keywords: